This cluster is routine and non-informative. The sales are overwhelmingly tied to option exercises and tax planning, not a coordinated bearish view. Monitor the next earnings release for fundamental trends, but this insider activity alone does not warrant a trade.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 27 $127.45entry
- T+1 · 6mo ago +4.43%α +3.87% · $133.09
- T+5 · 6mo ago −0.31%α −0.78% · $127.05
- T+20 · 5mo ago +7.46%α +9.75% · $136.96
- T+60 · 3mo ago +31.56%α +29.95% · $167.68
Price Chart
How similar events traded
Executive Summary
Six Guardant Health insiders sold a total of $4.36M in open-market sales over a 7-day window, led by the Chief Commercial Officer ($2.90M) and a Director ($735K). The cluster includes the Co-CEO ($20K), CLO ($593K), and two other directors. At $15.8B market cap, the total represents ~0.03% of market cap, a trivial proportion. The sales are likely liquidity-driven (option exercises and vesting) and carry no bearish signal per academic literature on cluster sells.
Key Financial Metrics
Key Facts
- 6 insiders sold shares totaling $4.36M in open-market transactions over 7 days
- Chief Commercial Officer Freeman sold 24,406 shares at $118.67 for $2.90M, largest trade
- Director Clark sold 6,876 shares at $106.90 for $735K
- Chief Legal Officer Saia sold 5,632 shares at $105.34 for $593K
- Co-CEO Talasaz sold only 200 shares at $100.95 for $20K, negligible
- Total sales represent ~0.03% of $15.8B market cap, well below 0.1% materiality threshold
- Multiple sales coincide with derivative exercises (Freeman exercised 24,406 options at $32.86; Hidalgo exercised 2,000 options at $32.55)
- No open-market purchases were made by any insider in this cluster
Financial Impact
Total insider sales of $4.36M represent 0.03% of $15.8B market cap, immaterial
Risk Factors
- Insider selling could accelerate if stock continues to appreciate, but no evidence of informed selling here
- Option exercises add ~50K shares to float, but dilution is negligible at 0.05% of shares outstanding
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GH-1779831510855 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers